Zhou et al. demonstrated that high IGF2BP3 expression correlated with poor survival rates of gastric cancer (GC) patients; moreover, IGF2BP3 knockdown significantly inhibited proliferation and invasion of GC cells [24]. Here, IGF2BP3 is linked to gastric cancer.